Ioanna Savvidou
0000-0002-3911-9741
Alfred Health, Monash University
2 papers found
Refreshing results…
Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma
Missing publications? Search for publications with a matching author name.